Genetically modified Shiga toxin 2e (Stx2e) producing Escherichia coli is a vaccine candidate for porcine edema disease

By Makino S-I.   Watarai M.   Tabuchi H.   Shirahata T.   Furuoka H.   Kobayashi Y.   Takeda Y.  

Microbial Pathogenesis, Vol. 31, Iss. 1, 2001-07 ,pp. : 1-8

Academic Press

Access to resources Recommend Favorite

T cell targeted immune enhancement yields effective T cell adjuvants

By Naylor P.H.   Hadden J.W.  

International Immunopharmacology, Vol. 3, Iss. 8, 2003-08 ,pp. : 1205-1215

Elsevier

Access to resources Recommend Favorite

Improvement of HBsAg Gene-Modified Dendritic Cell-Based Vaccine Efficacy by Optimizing Immunization Method or the Application of β-glucosylceramide

By Long Jianting  

Immunological Investigations, Vol. 42, Iss. 2, 2013-02 ,pp. : 137-155

Informa Healthcare

Access to resources Recommend Favorite

An antibody response to cholera toxin, but not soy proteins, following oral administration of adjuvanted soybean formulations

By Oakes Judy   Piller Kenneth   Bost Kenneth  

Food and Agricultural Immunology, Vol. 20, Iss. 4, 2009-12 ,pp. : 305-317

Taylor & Francis Ltd

Access to resources Recommend Favorite

Comparative study of the adjuvanticity of Bacillus thuringiensis Cry1Ab protein and cholera toxin on allergic sensitisation and elicitation to peanut

By Guimaraes V. D.   Drumare M. -F.   Ah-Leung S.   Lereclus D.   Bernard H.   Creminon C.   Wal J. -M.   Adel-Patient K.  

Food and Agricultural Immunology, Vol. 19, Iss. 4, 2008-12 ,pp. : 325-337

Taylor & Francis Ltd

Access to resources Recommend Favorite